QART Medical
Alon Shalev is a seasoned entrepreneur and executive with extensive experience in the medical and neuroscience sectors. As Co-Founder and CEO of QART Medical since 2018, Alon has been instrumental in driving innovation. Concurrently, Alon serves as Executive Chairman of Syncath Neuroscience Ltd. Alon's previous roles include External Board Member at Todos Medical and Board Member at Endospan, where Alon also held the CEO and Executive Vice President positions from 2008 to 2017. Alon co-founded SAMSON Neurosciences and led Nicast as CEO from 2004 to 2007. Earlier in Alon's career, Alon was the Founder and COO of Brainsgate from 2000 to 2004.
This person is not in any teams
This person is not in any offices
QART Medical
QART (Quantitative Assisted Reproductive Technologies) Medical, a clinical-stage MedTech company, addressing the global infertility epidemic. The Company develops a breakthrough solution for highly informative characterization and selection of sperm cells for in-vitro fertilization (IVF), aiming to create a new and better gold standard in the ART market. The QART system aims to improve current success rates of Intra-Cytoplasmic Sperm Injection (ICSI) by: * Quantitatively characterizing the morphology and contents of individual sperm cells with 3D topographic imaging * Providing quantitative DNA integrity information, on a cell-by-cell basis * Automatically sorting a semen sample according to objective consensus criteria.